6505--RFI - DRAFT SOW for PPV 2028
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA) is conducting market research by seeking industry review and feedback on a DRAFT Statement of Work (SOW), Definitions, and Distribution Fee Categories for the upcoming Pharmaceutical Prime Vendor (PPV) 2028 acquisition. This Request for Information (RFI) aims to ensure the final SOW is clear, comprehensive, and supports effective competition. Feedback is due by July 2, 2026, at 11 AM Central Time.
Scope of Work
The draft SOW outlines requirements for a PPV contract focused exclusively on pharmacy ordering. The PPV will be responsible for maintaining adequate supply and distributing drug/pharmaceutical items (Federal Supply Class 65) and other contracted items under various Federal Supply Schedules (FSS), BPAs, BOAs, and VA/DLA National Contracts. Key responsibilities include:
- Supplying specific product categories (e.g., single source innovator, generic, IV delivery systems, dietary supplements, certain medical/surgical products).
- Maintaining a minimum 98% fill-rate, calculated daily.
- Providing next-day delivery for most orders, with emergency deliveries within 12-24 hours.
- Adhering to specific expiration dating requirements for delivered products.
- Providing an electronic ordering system with bar code scanning, hand-held devices, software upgrades, and technical support at no cost.
- Complying with Drug Supply Chain Security Act (DSCSA) requirements.
- Providing various reports, including Velocity, Usage, Contract Compliance, and Sales Reports.
Key Areas for Feedback
Industry is invited to provide input on:
- Unclear, conflicting, or ambiguous requirements.
- Technical or operational requirements that may affect performance.
- Suggestions related to distribution operations, inventory management, reporting, data exchange, or order fulfillment processes.
- Noted risks, barriers, or areas needing additional definition.
- Suggestions to improve efficiency or align with industry best practices.
Contract & Timeline
- Type: Request for Information (RFI) / Sources Sought
- NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing)
- Set-Aside: None specified (market research stage)
- Response Due: July 2, 2026, 11 AM Central Time
- Published: June 12, 2026
- Point of Contact: Karen Ade, Karen.Ade@va.gov, 708-786-5231
Important Notes
This announcement is for market research purposes only and is not a solicitation. No contract will be awarded from this notice, and participation is voluntary and not a prerequisite for future solicitations. The Government will not reimburse any costs associated with providing comments.
Attached Documents
- DRAFT PPV28 SOW 6-11-2026.pdf: Outlines the detailed requirements for the PPV contract.
- DRAFT PPV28 Pricing Categories 6-11-2026.pdf: Details product categories and associated distribution fee payment terms (FASTPAY or NET30).
- DRAFT PPV28 Definitions 6-11-2026.pdf: Provides comprehensive definitions for terms used in the solicitation and contract, crucial for accurate interpretation.